1. Home
  2. IH vs ASMB Comparison

IH vs ASMB Comparison

Compare IH & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.65

Market Cap

84.1M

Sector

Real Estate

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$24.29

Market Cap

442.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
ASMB
Founded
1996
2005
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.1M
442.9M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
IH
ASMB
Price
$1.65
$24.29
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$44.20
AVG Volume (30 Days)
15.6K
176.5K
Earning Date
03-31-2026
05-06-2026
Dividend Yield
5.88%
N/A
EPS Growth
N/A
91.78
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$638.39
P/E Ratio
$7.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.55
$15.54
52 Week High
$3.60
$39.71

Technical Indicators

Market Signals
Indicator
IH
ASMB
Relative Strength Index (RSI) 49.54 34.39
Support Level $1.58 $20.23
Resistance Level $1.83 $31.21
Average True Range (ATR) 0.08 1.75
MACD 0.01 -0.42
Stochastic Oscillator 27.72 4.26

Price Performance

Historical Comparison
IH
ASMB

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: